Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: riluzole|GENETIC: polymorphism analysis|PROCEDURE: axillary lymph node biopsy|PROCEDURE: digital image analysis|PROCEDURE: needle biopsy|PROCEDURE: sentinel lymph node biopsy|PROCEDURE: therapeutic conventional surgery
Sponsor: Barbara Ann Karmanos Cancer Institute
Collaborators: National Cancer Institute (NCI)